Arkolith/Insider Trading/RGRX/Form 4

Goldstein Allan L

DirectorREGENERX BIOPHARMACEUTICALS INC (RGRX) · full profile →Form 4 · filed Mar 2, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 8, 2021Gift(G)130K—$01.5M

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-22-005012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML